SCHEMBL7881816

SCHEMBL7881816

CCCCCc1ccc2cc(C(=O)O)[nH]c2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G4A P47712 1/20 0.58
▸ EIF4A3 P38919 1/20 0.51
▸ KAT8 Q9H7Z6 2/20 0.50
▸ PPARA Q07869 2/20 0.50
▸ TBXAS1 P24557 1/20 0.50
▸ ALOX15 P16050 2/20 0.48
▸ MAPT P10636 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ DAO P14920 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ SRD5A2 P31213 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ PPARG P37231 1/20 0.47
▸ RARB P10826 5/20 0.47
▸ ALDH1A1 P00352 2/20 0.46
▸ S1PR4 O95977 1/20 0.46
▸ S1PR1 P21453 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ RARA P10276 1/20 0.46
▸ MTOR P42345 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15642858 0.89 PLA2G4A (0.67) PLA2G4AKAT8PPARATBXAS1MAPT
SCHEMBL1144575 0.83 DAO (0.58) EIF4A3TBXAS1ALOX15MAPTKDM4E
SCHEMBL8985815 0.79 TBXAS1 (0.57) EIF4A3TBXAS1MAPTKDM4EDAO
SCHEMBL9452266 0.78 KDM4E (0.56) PLA2G4AKDM4EHPGDHSD17B10RARB
SCHEMBL28474583 0.78 PIN1 (0.59) PLA2G4AEIF4A3TBXAS1MAPTKDM4E
SCHEMBL24076666 0.77 PLA2G4A (0.55) PLA2G4AEIF4A3MAPTKDM4EDAO
SCHEMBL27858828 0.77 TBXAS1 (0.50) EIF4A3TBXAS1MAPTKDM4EDAO
SCHEMBL27583744 0.77 TBXAS1 (0.50) EIF4A3TBXAS1MAPTKDM4EDAO
SCHEMBL18932519 0.76 GPR84 (0.47) MAPTDAOS1PR4S1PR1
SCHEMBL19592645 0.75 ALOX15 (0.51) EIF4A3TBXAS1ALOX15MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 — — CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 — — US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 — — US disclosed
CN-1051301-C Indoloylguanidine derivatives SUMITOMO PHARMA (JP) 2000-04-12 — — CN disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 — — EP disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 — — CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 — — EP disclosed
CN-1106800-A Indoloylguanidine derivatives SUMITOMO PHARMA (JP) 1995-08-16 — — CN disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 — — EP disclosed
Send feedback